or Try an Advanced Search...

    Technical Analysis for CVKD - Cadrenal Therapeutics, Inc.

    Grade Last Price % Change Price Change
    B 17.60 3.77% 0.64
    CVKD closed up 3.77 percent on Friday, November 1, 2024, on 1.31 times normal volume. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Up Up Up
    Historical CVKD trend table...
    Date Alert Name Type % Chg
    Stochastic Reached Overbought Strength 0.00%
    Wide Bands Range Expansion 0.00%
    Overbought Stochastic Strength 0.00%
    Up 3 Days in a Row Strength 0.00%
    Up 4 Days in a Row Strength 0.00%
    Gapped Down Weakness 0.00%
    MACD Bullish Signal Line Cross Bullish 3.77%
    Wide Bands Range Expansion 3.77%
    Up 3 Days in a Row Strength 3.77%
    Wide Bands Range Expansion 7.38%
    Older End-of-Day Signals for CVKD ...

       Recent Intraday Alerts

    Alert Time
    Rose Above Previous Day's High 1 day ago
    1.5x Volume Pace 1 day ago
    Down 5% 1 day ago
    Down 3% 1 day ago
    Up 5% 1 day ago
    View Earlier Intraday Alerts

    Get this analysis on your stocks daily!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    CVKD Chart by TradingView
    Basic chart:

    Profile

    Cadrenal Therapeutics, Inc. operates as a clinical development biopharmaceutical company. The company focuses on developing Tecarfarin, a novel therapy with orphan drug indication for the prevention of systemic thromboembolism of cardiac origin in patients with end-stage renal disease and atrial fibrillation. The company was incorporated in 2022 and is headquartered in Ponte Vedra, Florida.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Health Sciences Hematology End Stage Renal Disease Cardiac Arrhythmia Atrial Fibrillation Venous Thrombosis

    Is CVKD a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Nov 2 Cadrenal Therapeutics Announces Exercise of Warrants for $4.7 Million Gross Proceeds
    Oct 28 We're Keeping An Eye On Cadrenal Therapeutics' (NASDAQ:CVKD) Cash Burn Rate
    Oct 24 Cadrenal Therapeutics raises $5.1M via at-the-market facility
    Oct 24 Cadrenal Therapeutics Raises $5.1 Million via At-The-Market Facility
    Oct 23 CADRENAL THERAPEUTICS JOINS CORPORATE COUNCIL OF ANTICOAGULATION FORUM
    Sep 23 Cadrenal Therapeutics to Participate in Lytham Partners Fall 2024 Investor Conference
    Sep 12 Why Champions Oncology Shares Are Trading Higher By Over 13%; Here Are 20 Stocks Moving Premarket
    Sep 11 Investor Summit August 2024 Presentations Now Accessible for On-Demand Viewing
    Aug 22 Cadrenal Therapeutics Announces Upcoming Type-B FDA Meeting in September to Discuss Tecarfarin Trial in LVAD Patients
    Aug 20 Published Findings Highlight Tecarfarin's Potential and Reinforce Need for Better Anticoagulation Therapy in LVAD Patients
    See more CVKD news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 32.55
    52 Week Low 5.4
    Average Volume 51,534
    200-Day Moving Average 9.75
    50-Day Moving Average 12.03
    20-Day Moving Average 14.85
    10-Day Moving Average 15.80
    Average True Range 1.57
    RSI (14) 64.91
    ADX 31.86
    +DI 32.89
    -DI 13.26
    Chandelier Exit (Long, 3 ATRs) 13.28
    Chandelier Exit (Short, 3 ATRs) 15.72
    Upper Bollinger Bands 18.48
    Lower Bollinger Band 11.22
    Percent B (%b) 0.88
    BandWidth 48.87
    MACD Line 1.34
    MACD Signal Line 1.28
    MACD Histogram 0.0654
    Fundamentals Value
    Market Cap 229.2 Million
    Num Shares 13 Million
    EPS
    Price-to-Sales 0.00
    Price-to-Book 1.36
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 20.68
    Resistance 3 (R3) 20.47 19.23 20.16
    Resistance 2 (R2) 19.23 18.45 19.34 19.99
    Resistance 1 (R1) 18.42 17.97 18.83 18.63 19.82
    Pivot Point 17.18 17.18 17.39 17.29 17.18
    Support 1 (S1) 16.37 16.40 16.78 16.58 15.38
    Support 2 (S2) 15.13 15.92 15.24 15.21
    Support 3 (S3) 14.32 15.13 15.04
    Support 4 (S4) 14.53